Evolocumab Reduced CV Events in Diabetes - Top-Institutions - MDSpire

Evolocumab Reduced CV Events in Diabetes

Subgroup analysis of the VESALIUS-CV trial supports earlier intensive lipid lowering

  • By

  • Kathryn Wighton

  • April 1, 2026

  • 4 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Endocrinology
    • Lipidology

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Endocrinology
    • Clinical Research

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Endocrinology
    • Translational Medicine

  • #4

    University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Cardiology
    • Endocrinology
    • Clinical Trials

  • #5

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Cardiology
    • Endocrinology
    • Preventive Medicine

Original Source(s)

Evolocumab Reduced CV Events in Diabetes

  • by Kathryn Wighton

  • April 1, 2026

Related Content

Visceral fat area and visceral-to-subcutaneous fat ratio are more strongly associated with residual cholesterol than conventional anthropometric indices in adults with type 2 diabetes

Analysis of factors associated with cognitive impairment in elderly patients hospitalized with chronic heart failure

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.